Clinical Trials on Advanced Solid Tumors, Excluding Breast Cancer in France
Total 406 results
-
Novartis PharmaceuticalsRecruitingContinued Access to Study Treatment(s), Cancers With a Mass, Bulky Tumor, Nodule, Lump, Advanced Cancer, Advanced Solid Tumors, Advanced Solid MalignanciesSpain, Taiwan, United States, Singapore, France
-
Relay Therapeutics, Inc.RecruitingBreast Cancer | Advanced Breast Cancer | Metastatic Breast Cancer | Solid Tumor, Adult | HER2-negative Breast Cancer | Unresectable Solid Tumor | PIK3CA MutationUnited States, Spain, France, Italy
-
Centre Leon BerardBayerActive, not recruitingMetastatic Cancer | Solid Tumor, Adult | Locally Advanced Solid TumorFrance
-
Daiichi SankyoAstraZenecaRecruitingBreast Cancer | Advanced Solid TumorUnited States, Spain, Canada, France
-
Orinove, Inc.Active, not recruitingMetastatic Breast Cancer | Advanced Solid TumorUnited States
-
AbbVieActive, not recruitingAdvanced Solid Tumors CancerUnited States, Belgium, Finland, France, Italy, Japan, Korea, Republic of, Netherlands, Taiwan
-
Aadi Bioscience, Inc.Active, not recruitingMalignant Solid Neoplasm | Neoplasms | Cancer | Neoplasm Metastasis | Solid Tumor | Metastatic Cancer | Metastasis | Advanced Solid Tumor | Metastatic Solid Tumor | Advanced Cancer | Tumor | Malignant Neoplasm | Malignant Tumor | Tumors | Cancer Metastatic | Tumor, Solid | Malignant Solid Tumor | TSC | TSC1 | TSC2 | Metastatic NeoplasmUnited States, Korea, Republic of, Puerto Rico
-
Puma Biotechnology, Inc.CompletedBreast Cancer | Advanced Malignant Solid TumorsUnited States, Taiwan, United Kingdom, Hong Kong, Belgium, France, Spain, China, Netherlands, Poland, Sweden
-
Gustave Roussy, Cancer Campus, Grand ParisActive, not recruiting
-
Incyte CorporationRecruitingA Study to Evaluate the Safety of INCA33890 in Participants With Advanced or Metastatic Solid TumorsAdvanced Solid Tumors | Solid Tumors | Metastatic Solid TumorsUnited States, Spain, United Kingdom, France, Italy, Denmark, Switzerland
-
Taiho Oncology, Inc.CompletedAdvanced Solid TumorsFrance, Belgium, Italy, Switzerland
-
Nerviano Medical SciencesTerminatedAdvanced/Metastatic Solid TumorsUnited Kingdom, France
-
Centre Leon BerardNETRIS PharmaRecruitingAdvanced Solid Tumors | Metastatic Solid TumorsFrance
-
Hospices Civils de LyonUnknownMetastatic or Locally Advanced Solid TumorsFrance
-
Eisai LimitedCompletedAdvanced Solid TumorFrance
-
Pierre Fabre MedicamentActive, not recruitingAdvanced or Metastatic Solid TumorsFrance, Spain
-
Gustave Roussy, Cancer Campus, Grand ParisCompletedAdvanced or Metastatic Solid TumorsFrance
-
Hoffmann-La RocheCompletedAdvanced Solid TumorsUnited States, France
-
Molecular Partners AGCompletedAdvanced Solid TumorFrance
-
SanofiCompletedAdvanced Solid TumorFrance, Spain
-
Janssen Research & Development, LLCRecruitingAdvanced Solid TumorsUnited States, France, Spain
-
Gustave Roussy, Cancer Campus, Grand ParisRecruiting
-
Exscientia AI LimitedBiotrialTerminatedAdvanced Solid TumoursFrance, Belgium
-
Taiho Oncology, Inc.TerminatedAdvanced or Metastatic Solid Tumors Irrespective of Gene Alterations | Advanced or Metastatic Solid Tumors With Germline PTEN Inactivating MutationsUnited States, United Kingdom, Austria, France
-
Innate PharmaAstraZenecaTerminatedAdvanced Solid TumorsUnited States, France
-
Pierre Fabre MedicamentTerminatedLocally Advanced or Metastatic Solid TumorsFrance, Spain
-
MedImmune LLCCompletedAdvanced Solid TumorsUnited States, France, Spain, Switzerland
-
Gustave Roussy, Cancer Campus, Grand ParisUnknownPatients With Advanced or Metastatic Solid TumorsFrance
-
PfizerMedivation, Inc.CompletedAdvanced Solid TumorsUnited States
-
Shanghai Miracogen Inc.RecruitingAdvanced Solid Tumors | Advanced or Metastatic Gastric Cancer | Advanced or Metastatic Gastroesophageal Junction CancerUnited States
-
Astellas Pharma Global Development, Inc.CompletedAdvanced Solid TumorsGermany, Czechia, United States, Brazil, Poland, Singapore, Thailand
-
EMD Serono Research & Development Institute, Inc.Merck KGaA, Darmstadt, GermanyTerminatedAdvanced Solid TumorsSpain, United States, Netherlands, Hungary, Italy, France, Belgium
-
MedImmune LLCCompletedAdvanced Solid TumorsUnited States, Germany, Italy, United Kingdom, Belgium, Canada, Korea, Republic of, Taiwan, France
-
AmgenCompletedAdvanced Solid TumorsBelgium, Canada, Australia, United States, Spain, Poland, France, Germany, Japan, United Kingdom
-
Vall d'Hebron Institute of OncologyTaisho Pharmaceutical Co., Ltd.; Roche Pharma AG; Iqvia Pty Ltd; Janssen, LPRecruitingAdvanced Solid TumorSpain, France, Germany, Netherlands, Sweden, United Kingdom, Italy
-
AmgenRecruitingAdvanced Solid TumorsUnited States, Korea, Republic of, Spain, Australia, Germany, France, Japan, Canada
-
Novartis PharmaceuticalsRecruitingAdvanced Solid TumorsSwitzerland, Belgium, Italy, Spain, Germany, Hong Kong, Hungary, Korea, Republic of, China, Czechia, Canada, United States, France, Poland, Thailand, Netherlands, Taiwan
-
Tachyon Therapeutics, Inc.RecruitingSolid Tumor | Metastatic Solid Tumor | Advanced CancerUnited States
-
MedImmune LLCCompletedSelect Advanced Solid TumorsUnited States, France, Netherlands
-
Hoffmann-La RocheCompletedLocally Advanced Solid Tumors | Metastatic Solid TumorsUnited States, Korea, Republic of
-
Centessa Pharmaceuticals (UK) LimitedLockBody Therapeutics LtdRecruitingAdvanced Solid TumorUnited States, France
-
Cytovation ASMerck Sharp & Dohme LLCActive, not recruitingAdvanced Solid Tumor MalignancyNetherlands, France, Spain
-
Nuvalent Inc.RecruitingMetastatic Solid Tumor | Locally Advanced Solid TumorCanada, United States, Korea, Republic of, Taiwan, Spain, Australia, Belgium, France, Netherlands, Singapore, Germany
-
Bristol-Myers SquibbActive, not recruitingAdvanced Solid TumorsCanada, United States, Spain, France, Switzerland
-
Syros PharmaceuticalsTerminatedBreast Cancer | Ovarian Cancer | Advanced Solid TumorsUnited States, Canada, France
-
PharmaMarRecruitingAdvanced Solid TumorUnited States, Spain, France
-
Regeneron PharmaceuticalsRecruitingAdvanced Solid TumorsUnited States, Spain, Turkey, France
-
Centre Leon BerardRoche Pharma AGCompleted
-
Novartis PharmaceuticalsCompletedAdvanced Solid Tumors With Alterations of FGFR1, 2 and or 3 | Squamous Lung Cancer With FGFR1 Amplification | Bladder Cancer With FGFR3 Mutation or Fusion | Advanced Solid Tumors With FGFR1 Amplication | Advanced Solid Tumors With FGFR2 Amplication | Advanced Solid Tumors With FGFR3 MutationFrance, Spain, Taiwan, Germany, Netherlands, Singapore, United States, Australia, Korea, Republic of, Thailand, Israel, Italy, Turkey, Austria
-
PharmaMarCompletedAdvanced Solid TumorsSpain, United States, Belgium, France, Italy, Switzerland, Germany, Sweden, United Kingdom